FDA 483 - Human Subjects Research Committee - August 22, 2025

An FDA inspection of Hennepin County Med Ctr's Institutional Review Board (IRB) in Minneapolis revealed two significant observations. The IRB improperly used expedited review procedures for research that did not meet eligibility criteria. Additionally, the facility failed to retain copies of all initial research protocols submitted for review and approval.